查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522269

2024 年神经血管栓塞装置全球市场报告

Neurovascular Embolization Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

神经血管栓塞器械市场规模预计在未来几年将强劲增长，预计到 2028 年将以 6.9% 的年复合成长率（CAGR）增长至 16 亿美元。预测期内的预期成长是由于新兴市场的可用性增加、注重以患者为中心的护理、对神经血管疾病的认识提高、成像技术的进步以及研发投资的增加。预测期内的主要趋势包括个人化治疗策略、将人工智慧引入治疗计划、引入下一代栓塞材料、向门诊和门诊护理的转变以及先进栓塞技术的创新。

出血发生率的增加预计将推动神经血管栓塞器械市场的发展。出血是指因皮肤或黏膜破裂而在体内或体外发生的异常、不受控制的出血。人口老化、高血压的增加和抗凝血剂使用的增加导致出血的发生。神经血管栓塞装置透过阻断异常血管以限制出血并避免对大脑的进一步损伤，在出血性中风的治疗中发挥重要作用。例如，伦敦国王学院最近进行的一项研究发现，到 2050 年，英国70 岁至 95 岁人群中脑出血（一种特定类型的出血）的病例和死亡人数预计将增加 59.4%。因此，脑出血盛行率的上升正在推动神经血管栓塞设备市场的成长。

神经血管栓塞器械领域的主要企业正致力于开发屏蔽技术等技术先进的产品，以解决脑动脉瘤问题并增强其市场竞争力。屏蔽技术是指旨在提高脑动脉瘤治疗设备的有效性和安全性，同时也有助于其整体耐用性和寿命的先进特性。例如，总部位于爱尔兰的医疗保健技术公司 Medtronic PLC 于 2022 年 6 月在印度推出了第四代分流器 Pipeline Vantage with Shield Technology。该设备包括增强的设计功能，以提高血管内手术过程中的易用性和可靠性。透过促进血管内膜中的细胞增殖，它提供了一个支架，有助于动脉瘤的微创治疗，降低破裂风险并改善患者预后。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 市场促进和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年市场规模表现与成长
  • 市场规模预测与成长，2023-2028，2033F

第六章 市场细分

  • 全球神经血管栓塞装置市场：依产品分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 栓塞弹簧圈
  • 液体栓塞系统
  • 分流器支架
  • 动脉瘤夹
  • 其他的
  • 全球神经血管栓塞装置市场：依治疗方法分类的表现与预测，2018-2023、2023-2028F、2033F
  • 缺血性中风解决方案
  • 出血性中风解决方案
  • 全球神经血管栓塞器材市场：依适应症分類的表现与预测，2018-2023、2023-2028F、2033F
  • 脑动脉瘤
  • 动静脉畸形
  • 其他的
  • 全球神经血管栓塞设备市场：最终用户的表现和预测，2018-2023、2023-2028F、2033F
  • 医院
  • 门诊手术中心
  • 其他的

第 7 章 区域/国家分析

  • 全球神经血管栓塞设备市场：按地区分類的表现和预测，2018-2023、2023-2028F、2033F
  • 全球神经血管栓塞装置市场：按国家分類的表现和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 神经血管栓塞器材市场：竞争格局
  • 神经血管栓塞装置市场：公司简介
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Heraeus Holding
    • Stryker Corporation

第三十一章 其他重大及创新企业

  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co Ltd
  • MicroVention Inc
  • Balt USA LLC
  • Imperative Care Inc
  • InNeuroCo Inc
  • Acandis GmbH & Co KG
  • Rapid Medical Ltd

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18422

Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.

The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.

The neurovascular embolization devices market research report is one of a series of new reports from The Business Research Company that provides neurovascular embolization devices market statistics, including the neurovascular embolization devices industry global market size, regional shares, competitors with neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends, and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. These neurovascular embolization devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.15 billion in 2023 to $1.23 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the rising geriatric population, the increased prevalence of neurovascular disorders, improved healthcare infrastructure, the demand for minimally invasive procedures, and increased healthcare expenditure.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth during the forecast period can be credited to the broadening utilization in emerging markets, the focus on patient-centered care, heightened awareness regarding neurovascular disorders, progressions in imaging technologies, and augmented investments in research and development. Key trends in the projected period encompass personalized treatment strategies, the incorporation of artificial intelligence into treatment planning, the introduction of next-generation embolic materials, a transition towards outpatient and ambulatory procedures, and the innovation of advanced embolization techniques.

The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King's College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.

Major companies in the neurovascular embolization devices sector are concentrating on the development of technologically advanced products, such as shield technology, to address brain aneurysms and enhance their competitive position in the market. Shield Technology denotes an advanced attribute aimed at augmenting the effectiveness and safety of these devices while also contributing to their overall durability and longevity. For example, in June 2022, Medtronic PLC, an Ireland-based healthcare technology company, introduced the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter in India. This device incorporates enhanced design features to enhance usability and reliability during endovascular procedures. By fostering cell growth in the blood vessel's inner lining, the device provides a scaffold that aids in the minimally invasive treatment of aneurysms, reduces the risk of rupture, and enhances patient outcomes.

In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, InNeuroCo Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Emboline Inc, InspireMD Inc, QXMedical LLC, Vesalio LLC, EmbolX Inc

North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurovascular Embolization Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurovascular embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurovascular embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
  • 3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Heraeus Holding; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurovascular Embolization Devices Market Characteristics

3. Neurovascular Embolization Devices Market Trends And Strategies

4. Neurovascular Embolization Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Neurovascular Embolization Devices Market Size and Growth

  • 5.1. Global Neurovascular Embolization Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neurovascular Embolization Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neurovascular Embolization Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurovascular Embolization Devices Market Segmentation

  • 6.1. Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Embolization Coils
  • Liquid Embolic Systems
  • Flow Diversion Stents
  • Aneurysm Clips
  • Other Products
  • 6.2. Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ischemic Stroke Solution
  • Hemorrhagic Stroke Solutions
  • 6.3. Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Brain Aneurysms
  • Arteriovenous Malformation
  • Other Indications
  • 6.4. Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

7. Neurovascular Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Neurovascular Embolization Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neurovascular Embolization Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurovascular Embolization Devices Market

  • 8.1. Asia-Pacific Neurovascular Embolization Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurovascular Embolization Devices Market

  • 9.1. China Neurovascular Embolization Devices Market Overview
  • 9.2. China Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurovascular Embolization Devices Market

  • 10.1. India Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurovascular Embolization Devices Market

  • 11.1. Japan Neurovascular Embolization Devices Market Overview
  • 11.2. Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurovascular Embolization Devices Market

  • 12.1. Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurovascular Embolization Devices Market

  • 13.1. Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurovascular Embolization Devices Market

  • 14.1. South Korea Neurovascular Embolization Devices Market Overview
  • 14.2. South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurovascular Embolization Devices Market

  • 15.1. Western Europe Neurovascular Embolization Devices Market Overview
  • 15.2. Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurovascular Embolization Devices Market

  • 16.1. UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurovascular Embolization Devices Market

  • 17.1. Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurovascular Embolization Devices Market

  • 18.1. France Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurovascular Embolization Devices Market

  • 19.1. Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurovascular Embolization Devices Market

  • 20.1. Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurovascular Embolization Devices Market

  • 21.1. Eastern Europe Neurovascular Embolization Devices Market Overview
  • 21.2. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurovascular Embolization Devices Market

  • 22.1. Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurovascular Embolization Devices Market

  • 23.1. North America Neurovascular Embolization Devices Market Overview
  • 23.2. North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurovascular Embolization Devices Market

  • 24.1. USA Neurovascular Embolization Devices Market Overview
  • 24.2. USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurovascular Embolization Devices Market

  • 25.1. Canada Neurovascular Embolization Devices Market Overview
  • 25.2. Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurovascular Embolization Devices Market

  • 26.1. South America Neurovascular Embolization Devices Market Overview
  • 26.2. South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurovascular Embolization Devices Market

  • 27.1. Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurovascular Embolization Devices Market

  • 28.1. Middle East Neurovascular Embolization Devices Market Overview
  • 28.2. Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurovascular Embolization Devices Market

  • 29.1. Africa Neurovascular Embolization Devices Market Overview
  • 29.2. Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurovascular Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Neurovascular Embolization Devices Market Competitive Landscape
  • 30.2. Neurovascular Embolization Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Heraeus Holding
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Stryker Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Neurovascular Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Kaneka Corporation
  • 31.3. Terumo Corporation
  • 31.4. B Braun Melsungen AG
  • 31.5. Cook Medical LLC
  • 31.6. Integer Holdings Corporation
  • 31.7. Merit Medical Systems Inc
  • 31.8. Penumbra Inc
  • 31.9. Asahi Intecc Co Ltd
  • 31.10. MicroVention Inc
  • 31.11. Balt USA LLC
  • 31.12. Imperative Care Inc
  • 31.13. InNeuroCo Inc
  • 31.14. Acandis GmbH & Co KG
  • 31.15. Rapid Medical Ltd

32. Global Neurovascular Embolization Devices Market Competitive Benchmarking

33. Global Neurovascular Embolization Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

35. Neurovascular Embolization Devices Market Future Outlook and Potential Analysis

  • 35.1 Neurovascular Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Neurovascular Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Neurovascular Embolization Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer